RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O
     

-A +A

Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in
Multiple Sclerosis. Part 2 - Effect on White Matter Integrity

BARGHI A; ALLENDORFER JB; TAUB E; WOMBLE B; HICKS JM; USWATTE G; SZAFLARSKI JP; MARK VW
NEUROREHABIL NEURAL REPAIR , 2018, vol. 32, n° 3, p. 233-241
Doc n°: 187453
Localisation : Documentation IRR

D.O.I. : http://dx.doi.org/DOI:10.1177/1545968317753073
Descripteurs : AE3 - SEP, AD3 - MOTRICITE, AK15 - IRM

Constraint-induced movement therapy (CIMT) is a method of physical
rehabilitation that has demonstrated clinical efficacy in patients with chronic
stroke, cerebral palsy, and multiple sclerosis (MS). This pilot
randomized controlled trial tested whether CIMT can also induce increases in
white matter integrity in patients with MS. METHODS: Twenty adults with chronic
hemiparetic MS were randomized to receive either CIMT or complementary and
alternative medicine (CAM) treatment (reported in the first article of this
pair). Structural white matter change was assessed by tract-based spatial
statistics (TBSS); measures included fractional anisotropy (FA), mean diffusivity
(MD), axial diffusivity (AD), and radial diffusivity (RD). RESULTS: CIMT and CAM
groups did not differ in pretreatment disability or expectancy to benefit. As
noted in the companion paper, the motor activity log (MAL) improved more after
CIMT than CAM ( P < .001); the within-group effect size for CIMT was 3.7 (large
d' = 0.57), while for CAM it was just 0.7. Improvements in white matter integrity
followed CIMT and were observed in the contralateral corpus callosum (FA, P <
.05), ipsilateral superior occipital gyrus (AD, P < .05), ipsilateral superior
temporal gyrus (FA, P < .05), and contralateral corticospinal tract (MD and RD, P
< .05). CONCLUSION: CIMT produced a very large improvement in real-world limb use
and induced white matter changes in patients with hemiparetic MS when compared
with CAM. The findings suggest in preliminary fashion that the adverse changes in
white matter integrity induced by MS might be reversed by CIMT. CLINICAL TRIAL
REGISTRATION NUMBER: ClinicalTrials.gov (NCT01081275).

Langue : ANGLAIS

Mes paniers

4

Gerer mes paniers

0